OR WAIT null SECS
August 21, 2019
Pfizer is investing $500 million for the construction of a state-of-the-art gene therapy manufacturing facility in Sanford, NC.
August 19, 2019
The Birtley, UK facility added cleanroom, manufacturing, and testing facilities for biopharma manufacturing single-use systems.
August 14, 2019
The companies have entered into a manufacturing agreement for the production of Phase III clinical trial material.
August 12, 2019
The acquisition strengthens BioLife’s position as a supplier of disruptive, enabling solutions used for manufacturing, storage, and distribution of cell and gene therapies.
The new facility will manufacture biopharmaceutical products under cGMP conditions.
The acquisition expands Eurofins Genomics’ gene portfolio while bolstering Blue Heron’s production capabilities.
August 09, 2019
The acquisition will boost Bayer’s cell-therapy development programs, with an initial focus on neurology, cardiology, and immunology.
The facility will support gene therapy production and continued development of PTC’s pipeline of investigational medicines.
August 08, 2019
The company has launched new services for mammalian cell bank manufacturing under GMP conditions.
August 02, 2019
As vaccines gain prominence within pharma, there is an expectation that specialized CDMO services will provide opportunities.